Singapore markets closed

Coherus BioSciences, Inc. (CHRS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.9850-0.0150 (-0.75%)
As of 12:39PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
257,244
257,244
211,042
326,551
475,824
Cost of revenue
158,992
158,992
70,083
57,591
37,667
Gross profit
98,252
98,252
140,959
268,960
438,157
Operating expenses
Research development
109,436
109,436
199,358
363,105
142,759
Selling general and administrative
192,015
192,015
198,481
169,713
139,079
Total operating expenses
301,451
301,451
397,839
532,818
281,838
Operating income or loss
-203,199
-203,199
-256,880
-263,858
156,319
Interest expense
40,542
40,542
32,474
22,959
21,166
Total other income/expenses net
5,469
5,469
-2,400
-283
554
Income before tax
-238,272
-238,272
-291,754
-287,100
135,707
Income tax expense
-380
-380
0
0
3,463
Income from continuing operations
-237,892
-237,892
-291,754
-287,100
132,244
Net income
-237,892
-237,892
-291,754
-287,100
132,244
Net income available to common shareholders
-237,892
-237,892
-291,754
-287,100
132,244
Basic EPS
-2.55
-2.53
-3.76
-3.81
1.85
Diluted EPS
-2.55
-2.53
-3.76
-3.81
1.62
Basic average shares
85,698
94,163
77,630
75,450
71,412
Diluted average shares
85,698
94,163
77,630
75,450
83,492